4.37  -0.89 (-16.92%)		06-18 16:00
Open: 4.96 High: 5.1618 Volume: 255,899		Pre. Close: 5.26 Low: 3.7 Market Cap: 12(M)

Short term
Mid term
Targets	6-month :	11.51	1-year :	17.28
Resists	First :	9.85	Second :	14.8
Pivot price	3.5
Supports	First :	1.86	Second :	1.54
MAs	MA(5) :	5.45	MA(20) :	3.22
	MA(100) :	2.92	MA(250) :	13.17
MACD	MACD :	0.7	Signal :	0.4
%K %D	K(14,3) :	23.8	D(3) :	31.6
RSI	RSI(14): 55.3
52-week	High :	76	Low :	1.75

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CUPR ] has closed below upper band by 36.9%. Bollinger Bands are 421.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	5.17 - 5.2	5.2 - 5.23
Low:	3.65 - 3.68	3.68 - 3.7
Close:	4.32 - 4.38	4.38 - 4.41

Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.

Tue, 16 Jun 2026
Tuesday's pre-market session: top gainers and losers - ChartMill

Mon, 15 Jun 2026
What's Going On With Cuprina Stock Monday? - Benzinga

Sat, 13 Jun 2026
Cuprina Holdings Regains Nasdaq Compliance and Avoids Delisting - The Globe and Mail

Fri, 12 Jun 2026
Why Cuprina Holdings Stock Is Surging Today? - Cuprina Holdings (Cayman) (NASDAQ:CUPR) - Benzinga

Fri, 12 Jun 2026
Cuprina regains compliance with Nasdaq listing requirements - Investing.com

Fri, 12 Jun 2026
Cuprina Holdings Regains Compliance with Nasdaq Capital Markets Listing Requirements - Quiver Quantitative

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	-6 (M)
Shares Float	0 (M)
Held by Insiders	920620 (%)
Held by Institutions	920630 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	-645
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-1.42
Profit Margin	0 %
Operating Margin	-10 %
Return on Assets (ttm)	568.3 %
Return on Equity (ttm)	-59 %
Qtrly Rev. Growth	569 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	-4.79e+006 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	-3.08
Price to Sales	0
Price to Cash Flow	0

Dividend	85190
Forward Dividend	11780
Dividend Yield	1949430%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.